Cas:17397-93-2 Tanshinone IIB manufacturer & supplier

Chemical Name:Tanshinone IIB

CAS.NO:17397-93-2

Synonyms:Phenanthro[1,2-b]furan-10,11-dione, 6,7,8,9-tetrahydro-6-(hydroxymethyl)-1,6-dimethyl-, (6S)-;(6S)-6-(Hydroxymethyl)-1,6-dimethyl-6,7,8,9-tetrahydrophenanthro[1,2-b]furan-10,11-dione

Molecular Formula:C₁₉H₁₈O₄

Molecular Weight:310.344

HS Code:2932999099

Physical and Chemical Properties:

Melting point:N/A

Boiling point:536.9±50.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.606

PSA:67.51000

Exact Mass:310.120514

LogP:3.80

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Phenanthro[1,2-b]furan-10,11-dione, 6,7,8,9-tetrahydro-6-(hydroxymethyl)-1,6-dimethyl-, (6S)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(6S)-6-(Hydroxymethyl)-1,6-dimethyl-6,7,8,9-tetrahydrophenanthro[1,2-b]furan-10,11-dione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(6S)-6-(Hydroxymethyl)-1,6-dimethyl-6,7,8,9-tetrahydrophenanthro[1,2-b]furan-10,11-dione Use and application,(6S)-6-(Hydroxymethyl)-1,6-dimethyl-6,7,8,9-tetrahydrophenanthro[1,2-b]furan-10,11-dione technical grade,usp/ep/jp grade.

Related News: In approving the first new Alzheimer’s drug in nearly 20 years, the U.S. Food and Drug Administration is taking its biggest risk yet with a strategy that allows new therapies onto the market without strong evidence that they work, regulatory and scientific experts say. Tanshinone IIB manufacturer ��No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,�� said Kristen Devito, Global Director, Catalent Clinical Supply Services. Tanshinone IIB supplier The fine and functional chemicals sector provides new growth drivers. Tanshinone IIB vendor Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application. Tanshinone IIB factory ��No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,�� said Kristen Devito, Global Director, Catalent Clinical Supply Services.